In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates-Reference-Cited by-同舟云学术

In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates

Published:1991-08 Issue:1-2 Volume:557 Page:167-176
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Brouillet Emmanuel,Chavoix Chantal,Bottlaender Michel,Khalili-Varasteh Marina,Hantraye Philippe,Fournier Denis,Dodd Robert H.,Mazière Mariannick

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference70 articles.

1. The partial inverse benzodiazepine agonist Ro15-4513 antagonizes acute ethanol effects in mice and rats;Bonnetti;Br. J. Pharmacol.,1985

2. Ro15-4513: partial inverse agonism at the BDZr and interaction with ethanol;Bonnetti;Pharmacol. Biochem. Behav.,1989

3. A method for the in vivo investigation of the serotoninergic 5-HT2 receptors in human cerebral cortex using positron emission tomography and18F-labeled setoperone;Blin;J. Neurochem.,1990

4. High densities of benzodiazepine receptors in human cortical areas;Braestrup;Nature,1977

5. Ligands for benzodiazepine receptors with positive and negative efficacy;Braestrup;Biochem. Pharmacol.,1984

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safe Deprescribing of Benzodiazepines and Z‐drugs;The Maudsley Deprescribing Guidelines – Antidepressants, Benzodiazepines, Gabapentinoids and Z‐drugs;2024-08-30

2. Discontinuation of psychotropic medication: a synthesis of evidence across medication classes;Molecular Psychiatry;2024-03-19

3. Brain PET imaging using ¹¹C-flumazenil and ¹¹C-buprenorphine does not support the hypothesis of a mutual interaction between buprenorphine and benzodiazepines at the neuroreceptor level;Journal of Cerebral Blood Flow & Metabolism;2023-12-14

4. Depression and Anxiety Disorders;The Maudsley Prescribing Guidelines in Psychiatry;2021-12-17

5. Tapering of SSRI treatment to mitigate withdrawal symptoms;The Lancet Psychiatry;2019-06